Gelesis Reports Fourth Quarter and Full Year 2022 Results Mar 28, 2023 07:00AM
Gelesis to Participate in the 25th Annual ICR Conference Jan 5, 2023 07:00AM
PureTech Provides End of Year Report on Key Progress Dec 22, 2022 02:00AM
Gelesis Reports Upcoming Participation in Wolfe Research’s Annual Consumer Growth Conference Nov 21, 2022 07:00AM
Gelesis Reports Third Quarter 2022 Results Nov 14, 2022 07:00AM


Nov 7, 2022 07:00AM Gelesis to Report Third Quarter 2022 Financial Results on November 14, 2022
Nov 2, 2022 07:30AM Data Presented at Obesity Week Demonstrate that Gelesis Investigational Clinical-Stage Oral Superabsorbent Hydrogel Gel-B Preferentially Enhances the Growth of Akkermansia muciniphila in Preclinical M
Nov 1, 2022 05:24PM Dr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis’ Oral Hydrogel Treatment GS200 at Obesity Week
Sep 8, 2022 07:00AM Gelesis to Participate in the Jefferies Virtual Fitness & Wellness Summit
Aug 25, 2022 07:00AM Clinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrom
Aug 25, 2022 02:07AM PureTech Health plc – Half-Year Report
Aug 17, 2022 08:00AM Gelesis to Participate in Fireside Chat with IPO Edge Today at 2:00 PM ET
Aug 15, 2022 07:00AM Gelesis Reports Second Quarter 2022 Results
Aug 4, 2022 04:05PM Gelesis to Report Second Quarter 2022 Financial Results on August 15, 2022
Jun 21, 2022 07:17AM Gelesis Holdings (GLS) Announces Additional $15 Million Pre-Order for Plenity
Jun 21, 2022 06:30AM Gelesis Announces Additional $15 Million Pre-Order for Plenity®, Bringing Total Pre-Paid Orders from Ro for Plenity to $55 Million
Jun 5, 2022 08:00AM Over the Past Decade, Person-First Language Was Used in Only About Half of Diabetes-Focused Articles and Fewer than 1% of Obesity Articles, Finds New Study
Jun 4, 2022 11:00AM Microbiota Transplantation Demonstrates How Gut Bacteria Contributes to Weight Loss and Beneficial Metabolic Effects with Gelesis’ Proprietary Hydrogel
May 18, 2022 04:05PM Gelesis to Participate in Upcoming Investor Conferences
May 12, 2022 04:00PM Gelesis Reports First Quarter 2022 Results
May 9, 2022 06:00AM Gelesis to Report First Quarter 2022 Financial Results on May 12, 2022
May 4, 2022 06:35AM PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022
May 4, 2022 06:31AM Gelesis Holdings (GLS) Reports Data Demonstrating Weight Loss With GS200 in Adults With Prediabetes and Type 2 Diabetes
May 4, 2022 06:31AM Clinical Data Presented at the European Congress on Obesity 2022 Demonstrates Weight Loss With GS200 in Adults With Prediabetes and Type 2 Diabetes
Apr 29, 2022 06:05AM PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Hea
Apr 29, 2022 06:01AM Gelesis Holdings (GLS) Reports its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia
Apr 29, 2022 06:00AM Gelesis’ Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study
Mar 24, 2022 04:00PM Gelesis® Reports Fiscal Year 2021 Results and Fiscal Year 2022 Financial Outlook
Mar 17, 2022 06:30AM Gelesis to Report Full Year 2021 Financial Results on March 24, 2022
Mar 16, 2022 06:36AM PureTech Health's (PRTC) Gelesis Holdings (GLS) Reports Record Preliminary National Launch Results for Plenity
Mar 16, 2022 06:35AM PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
Mar 16, 2022 06:30AM Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
Jan 31, 2022 06:50AM PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms
Jan 31, 2022 06:45AM Plenity® National Media Campaign Kicking Off Today Challenges Restrictive Dieting Norms
Jan 26, 2022 07:02AM PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I
Jan 13, 2022 06:41PM Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar
Jul 19, 2021 07:04AM Gelesis to Become Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp. (CPSR)